Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis

Jennifer Chae-Kim; Gunjal Garg; Larisa Gavrilova-Jordan; Lindsay E Blake; Tongil "TI" Kim; Qiang Wu; Clifford C Hayslip

doi:10.1136/ijgc-2021-002699

Article info

other Versions

You are currently viewing an earlier version of this article (April 26, 2022).
View the most recent version of this article

Original research

Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis

Authors

Jennifer Chae-Kim Department of Obstetrics and Gynecology, East Carolina University Brody School of Medicine, Greenville, North Carolina, USADepartment of Obstetrics and Gynecology, Baylor Scott & White Medical Center Temple, Temple, Texas, USA PubMed articles Google scholar articles
Gunjal Garg Division of Gynecologic Oncology, East Carolina University Brody School of Medicine, Greenville, North Carolina, USA PubMed articles Google scholar articles
Larisa Gavrilova-Jordan Division of Reproductive Endocrinology, Infertility and Genetics, Augusta University Medical College of Georgia, Augusta, Georgia, USA PubMed articles Google scholar articles
Lindsay E Blake University of Arkansas for Medical Sciences Library, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA PubMed articles Google scholar articles
Tongil "TI" Kim Department of Marketing, Naveen Jindal School of Management, The University of Texas at Dallas, Richardson, Texas, USA PubMed articles Google scholar articles
Qiang Wu Department of Biostatistics, East Carolina University, Greenville, North Carolina, USA PubMed articles Google scholar articles
Clifford C Hayslip Division of Reproductive Endocrinology and Infertility, East Carolina University Brody School of Medicine, Greenville, North Carolina, USA PubMed articles Google scholar articles

Correspondence to Dr Jennifer Chae-Kim, Department of Obstetrics and Gynecology, Baylor Scott & White Medical Center Temple, Temple, Texas, USA; jennifer.chaekim{at}bswhealth.org

View Full Text

Citation

Chae-Kim J, Garg G, Gavrilova-Jordan L, et al

Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis

International Journal of Gynecologic Cancer Published Online First: 16 November 2021. doi: 10.1136/ijgc-2021-002699

Publication history

Received April 14, 2021
Accepted October 6, 2021
First published November 16, 2021.

Article Versions

You are currently viewing a Previous version of this article (26 April 2022).
View the most recent version of this article

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password